Carlo Tanzi | IR Officer |
Eric Shaff | President and CEO |
Lisa von Moltke | EVP and Chief Medical Officer |
Terri Young | Chief Commercial Officer |
David Arkowitz | EVP, CFO and Head of Business Development |
Matthew Henn | Chief Scientific Officer |
Joseph Thome | TD Cowen |
Edward Tenthoff | Piper Sandler |
Tessa Romero | JPMorgan |
Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Seres Therapeutics's Second Quarter Earnings Conference Call. [Operator Instructions]
I would now like to turn the conference over to Dr.